Sign In
Get Clay Free →

Suggestions

    Susan Dillon

    President & CEO at Aro Biotherapeutics Company

    Susan Dillon, also known as Sue Dillon, is a highly accomplished professional and a co-founder of Aro Biotherapeutics, focusing on innovative drug delivery solutions using the Centyrins protein platform for diseases with significant unmet medical needs. Prior to her current role, Sue held various leadership positions at Centocor and Janssen Research & Development, a division of Johnson & Johnson Pharmaceuticals, from 2001 to 2017. In 2009, she was appointed as the Global Therapeutic Area Head for immunology at Janssen, overseeing the drug discovery, biomarkers, translational medicine, and clinical development of several groundbreaking products for autoimmune disorders.

    Susan Dillon
    Add to my network

    Location

    Greater Philadelphia Area